Skip to content
Screener

Free cash flow margin at other companies

Eli Lilly logo
Eli LillyLLY
22.8%+13.7pp
AbbVie logo
AbbVieABBV
31.8%+5.0pp
Apyx Medical Corporation logo
Apyx Medical CorporationAPYX
-16.1%-4.8pp
Establishment Labs logo
Establishment LabsESTA
-16.9%-6.4pp
Bausch Health Companies logo
Bausch Health CompaniesBHC
9.8%-2.8pp

Other financials

Income statement

See full
Revenue$42.9M-2.5%
Gross profit$26.3M-1.8%
Operating income-$29.0K-104%
Net income-$1.1M-88.2%
EPS (diluted)-$0.02-100%

Balance sheet

See full
Cash & equivalents$18.8M+130%
Total debt$70.5M-17.4%
Total equity$104.8M+16.4%
Total assets$193.3M-2.6%

Cash flow

See full
Operating cash flow$5.3M+507%
CapEx$228.0K-14.0%
Free cash flow$5.2M+605%

Valuation

See full
Market cap$194M-50.2%
Enterprise value$245.64M-47.4%
P/S1.3×-1.1×

Profitability

See full
Gross margin59.7%+0.6pp
Operating margin-8.4%+14.7pp
Net margin-11.3%-25.1pp

Returns & leverage

See full
Return on equity-21.6%-78.3pp
Debt / equity0.7×-0.3×
Current ratio0.8×+0.2×

Where this comes from

Calculated from AirSculpt Technologies, Inc.’s reported figures.

Based on trailing twelve months.

The source filing: AirSculpt Technologies, Inc.’s 10-Q, filed August 10, 2026. Open the filing →

Filed
Aug 10, 2026, 9:37 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001870940-26-000038

FAQ

What is AirSculpt Technologies, Inc.'s free cash flow margin?
AirSculpt Technologies, Inc. (AIRS) reported free cash flow margin of -0.1% in Q2 2025.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.

Ask your AI about AirSculpt Technologies, Inc.'s free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude